Harold J. Wanebo,
#136,058
Most Influential Person Now
Harold J. Wanebo,'s AcademicInfluence.com Rankings
Harold J. Wanebo,philosophy Degrees
Philosophy
#6874
World Rank
#9986
Historical Rank
Logic
#3967
World Rank
#5205
Historical Rank
Download Badge
Philosophy
Why Is Harold J. Wanebo, Influential?
(Suggest an Edit or Addition)Harold J. Wanebo,'s Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Cancer of the stomach. A patient care study by the American College of Surgeons. (1993) (690)
- Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. (1996) (617)
- Soft tissue sarcoma. (1997) (476)
- Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. (1978) (470)
- Long-Term Results of a Multi-Institutional Randomized Trial Comparing Prognostic Factors and Surgical Results for Intermediate Thickness Melanomas (1.0 to 4.0 mm) (2000) (419)
- Pelvic resection of recurrent rectal cancer (1994) (353)
- Head and Neck Sarcoma: Report of the Head and Neck Sarcoma Registry (1992) (238)
- Long-Term Results of a Prospective Surgical Trial Comparing 2 cm vs. 4 cm Excision Margins for 740 Patients With 1–4 mm Melanomas (2001) (233)
- Giant condyloma acuminatum (Buschke-Lowenstein tumor) of the anorectal and perianal regions (1994) (230)
- Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. (2000) (214)
- Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. (2001) (196)
- Anorectal melanoma (1981) (188)
- Surgical management of patients with primary operable colorectal cancer and synchronous liver metastases. (1978) (183)
- Pelvic recurrence of rectal cancer. Options for curative resection. (1987) (178)
- Patient selection for hepatic resection of colorectal metastases. (1996) (172)
- T-cell deficiency in patients with squamous cell cancer of the head and neck. (1975) (163)
- Malignant melanoma of the extremities: A clinicopathologic study using levels of invasion (microstage) (1975) (156)
- Pelvic resection of recurrent rectal cancer: technical considerations and outcomes. (1999) (153)
- Younger women with breast carcinoma have a poorer prognosis than older women (1996) (153)
- Abdominal Sacral Resection of Locally Recurrent Rectal Cancer (1981) (147)
- Wound-induced tumor progression: a probable role in recurrence after tumor resection. (1998) (145)
- Prognostic and therapeutic use of microstaging of cutaneous squamous cell carcinoma of the trunk and extremities (1985) (139)
- Tumor necrosis factors. (1989) (135)
- Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer. (2000) (134)
- Results of surgical treatment of nonhepatic recurrence of colorectal carcinoma (1993) (126)
- Oncogene Protein Co‐Expression Value of Ha-ras, c-myc, c-fos, and p53 as Prognostic Discriminants for Breast Carcinoma (1995) (123)
- Is surgical management compromised in elderly patients with breast cancer? (1997) (121)
- Cetuximab with concurrent chemoradiation for esophagogastric cancer: assessment of toxicity. (2008) (120)
- Selection of the Optimum Surgical Treatment of Stage I Melanoma By Depth of Microinvasion: Use of the Combined Microstage Technique (Clark‐Breslow) (1975) (120)
- Role of splenectomy in gastric cancer surgery: adverse effect of elective splenectomy on longterm survival. (1997) (118)
- Suspected recurrent rectosigmoid carcinoma after abdominoperineal resection: MR imaging and histopathologic findings. (1989) (118)
- Is Carcinoma of the Gallbladder a Curable Lesion? (1982) (116)
- Pancreatic carcinoma in perspective: A continuing challenge (1996) (111)
- Treatment of minimal breast cancer (1974) (109)
- Prognostic factors and management considerations in patients with cervical metastases of thyroid cancer. (1992) (107)
- Fine needle aspiration cytology in lieu of open biopsy in management of primary breast cancer. (1984) (104)
- Phase II Study of External Irradiation and Weekly Paclitaxel for Nonmetastatic, Unresectable Pancreatic Cancer: RTOG-98-12 (2004) (101)
- Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions. (1996) (100)
- Impact of sentinel node status and other risk factors on the clinical outcome of head and neck melanoma patients. (2006) (99)
- A rationale for expanding the endpoints for clinical trials in advanced pancreatic carcinoma (1996) (99)
- Transient stimulation of the c-Jun-NH2-terminal kinase/activator protein 1 pathway and inhibition of extracellular signal-regulated kinase are early effects in paclitaxel-mediated apoptosis in human B lymphoblasts. (1998) (98)
- Prognostic factors in head and neck melanoma. Effect of lesion location (1988) (98)
- Gastric carcinoma: does lymph node dissection alter survival? (1996) (94)
- The influence of the surgical wound on local tumor recurrence. (1989) (92)
- Circulating immune complexes detected by 125I-Clq deviation test in sera of cancer patients. (1977) (91)
- Total thyroidectomy does not enhance disease control or survival even in high-risk patients with differentiated thyroid cancer. (1998) (88)
- Current perspectives on repeat hepatic resection for colorectal carcinoma: a review. (1996) (88)
- The effect of surgical wounding on tumour development. (1999) (88)
- The acute and chronic effects of alcohol on the human immune system. (1975) (87)
- Paclitaxel and concurrent radiation for locally advanced pancreatic and gastric cancer: a phase I study. (1997) (79)
- Preoperative regional therapy for extremity sarcoma. A tricenter update (1995) (79)
- Regression in thin malignant melanoma. Microscopic diagnosis and prognostic importance. (1985) (79)
- Head and neck sarcoma: report of the Head and Neck Sarcoma Registry. Society of Head and Neck Surgeons Committee on Research. (1992) (77)
- Factors Predictive of the Status of Sentinel Lymph Nodes in Melanoma Patients from a Large Multicenter Database (2011) (77)
- Delayed hypersensitivity reactions in patients with squamous cell cancer of the head and neck. (1974) (76)
- Decreased complement mediated binding of antibody/3H-dsDNA immune complexes to the red blood cells of patients with systemic lupus erythematosus, rheumatoid arthritis, and hematologic malignancies. (1983) (75)
- Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup Study. (1987) (75)
- The impact of histopathology on nodal metastases in minimal breast cancer. (1997) (75)
- Diagnosis and management of giant intrasacral schwannoma (1992) (75)
- Thyroid cancer: some basic considerations. (1981) (74)
- Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells. (2006) (74)
- Paraproteinemia and Reticulum Cell Sarcoma in an Inbred Mouse Strain (1966) (73)
- Paclitaxel and concurrent radiation for locally advanced pancreatic cancer. (2001) (72)
- Combined cytotoxic action of paclitaxel and ceramide against the human Tu138 head and neck squamous carcinoma cell line (2000) (72)
- A southeastern cancer study group phase I/II trial with vaccinia melanoma oncolysates (1986) (70)
- Bilateral Breast Cancer Risk Reduction by Contralateral Biopsy (1985) (70)
- Localized carcinoma of the external ear is an unrecognized aggressive disease with a high propensity for local regional recurrence. (1992) (69)
- Squamous cell carcinoma in the immunosuppressed patient: Fanconi's anemia. (1985) (69)
- Age correlates with increased frequency of high risk factors in elderly patients with thyroid cancer. (1995) (68)
- Production of and response to interleukin‐2 in peripheral blood lymphocytes of cancer patients (1986) (64)
- Changing patterns of failure of head and neck cancer. (2002) (62)
- Prospective monitoring trial for carcinoma of colon and rectum after surgical resection. (1989) (62)
- Concurrent cis-platinum and radiation with or without surgery for advanced head and neck cancer. (1994) (62)
- Trastuzumab, paclitaxel, cisplatin, and radiation for adenocarcinoma of the esophagus: a phase I study. (2004) (61)
- Paclitaxel, Cisplatin, and Concurrent Radiation for Esophageal Cancer (2001) (60)
- Lobular carcinoma in situ of the breast: mammographic features. (1988) (60)
- Immunologic evaluation and prognosis in patients with head and neck cancer. (1977) (59)
- Positive relationship of clinical and serologic responses to vaccinia melanoma oncolysate. (1987) (58)
- Immunogenic properties of reticulum cell sarcomas of SJL/J mice. (1970) (57)
- Surgical Resection Is Necessary To Maximize Tumor Control in Function-Preserving, Aggressive Chemoradiation Protocols for Advanced Squamous Cancer of the Head and Neck (Stage III and IV) (2001) (57)
- Composite resection of posterior pelvic malignancy. (1992) (57)
- Preoperative radiation therapy for rectal cancer. An effective therapy in need of a clinical trial. (1986) (52)
- Optimal surgical treatment of invasive lobular carcinoma of the breast (1997) (50)
- Targeted inhibition of transient activation of the EGFR-mediated cell survival pathway enhances paclitaxel-induced ovarian cancer cell death. (2005) (50)
- Indomethacin sensitive suppressor‐cell activity in head and neck cancer patients: The role of the adherent mononuclear cell (1988) (49)
- Thyroid cancer: Some basic considerations (1983) (49)
- Prognostic factors in head and neck melanoma (1989) (49)
- Paclitaxel and Ceramide synergistically induce cell death with transient activation of EGFR and ERK pathway in pancreatic cancer cells (2006) (47)
- Transient activation of EGFR/AKT cell survival pathway and expression of survivin contribute to reduced sensitivity of human melanoma cells to betulinic acid. (2005) (46)
- Radionuclide lymphoscintigraphy with technetium 99m antimony sulfide colloid to identify lymphatic drainage of cutaneous melanoma at ambiguous sites in the head and neck and trunk (1985) (46)
- Pseudo-obstruction of the colon. (1971) (45)
- Preoperative chemotherapy and radiation therapy for stage IIIa carcinoma of the lung. (1992) (45)
- Paclitaxel-induced apoptosis in Jurkat, a leukemic T cell line, is enhanced by ceramide. (1999) (44)
- Primary gastric lymphoma. Problems in staging and management. (1988) (44)
- Meeting the biologic challenge of colorectal metastases (2012) (43)
- Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: a phase II ECOG-ACRIN trial (E2303). (2014) (43)
- Immune reactivity in primary carcinoma of the lung and its relation to prognosis. (1976) (41)
- Repeat Hepatic Resection for Recurrent Colorectal Cancer (1997) (41)
- Laparoscopic Cholecystectomy: Its Effect on the Prognosis of Patients with Gallbladder Cancer (2004) (41)
- Chemoradiotherapy for advanced inoperable head and neck cancer: A phase II study. (1999) (41)
- Phase II evaluation of cetuximab (C225) combined with induction paclitaxel and carboplatin followed by C225, paclitaxel, carboplatin, and radiation for stage III/IV operable squamous cancer of the head and neck (ECOG, E2303) (2007) (40)
- Isolated pelvic perfusion for unresectable cancer using a balloon occlusion technique. (1993) (40)
- Thin (<1 mm) Melanomas of the Extremities Are Biologically Favorable Lesions Not Influenced by Regression (1985) (40)
- Intralesional injection of the methanol extraction residue of bacillus calmette‐guerin (MER) into cutaneous metastases of malignant melanoma (1978) (38)
- DELAYED CUTANEOUS HYPERSENSITIVITY REACTIONS AND PROGNOSIS IN PATIENTS WITH CANCER (1976) (37)
- Thin #1 mm Level III and IV Melanomas Are Higher Risk Lesions For Regional Failure and Warrant Sentinel Lymph Node Biopsy (2000) (36)
- Paclitaxel and concurrent radiation therapy for locally advanced adenocarcinomas of the pancreas, stomach, and gastroesophageal junction. (1999) (35)
- RANDOMIZED TRIAL OF BACILLUS CALMETTE‐GUÉRIN (PERCUTANEOUS ADMINISTRATION) AS SURGICAL ADJUVANT IMMUNOTHERAPY FOR PATIENTS WITH STAGE‐II MELANOMA (1976) (35)
- Prognostic evaluation of regional lymph node morphology colorectal cancer. (1975) (34)
- Interleukin-10 as a possible mediator of immunosuppressive effect in patients with squamous cell carcinoma of the head and neck (1997) (34)
- Contribution of serum inhibitory factors and immune cellular defects to the depressed cell-mediated immunity in patients with head and neck cancer. (1993) (33)
- Surgical management and treatment of gastric and duodenal fistulas. (1996) (33)
- Immunologic reactivity in patients with primary operable breast cancer (1978) (33)
- Immunobiology of head and neck cancer: basic concepts. (1979) (32)
- Preoperative cisplatin and accelerated hyperfractionated radiation induces high tumor response and control rates in patients with advanced head and neck cancer. (1995) (32)
- Radionuclide lymphoscintigraphy with technetium 99m antimony sulfide colloid to identify lymphatic drainage of cutaneous melanoma at ambiguous sites in the head and neck and trunk. (1985) (32)
- Pelvic exenteration for recurrent rectal cancer. (1996) (32)
- Preoperative therapy for advanced pelvic malignancy by isolated pelvic perfusion with the balloon-occlusion technique (1996) (32)
- Composite pelvic resection. An approach to advanced pelvic cancer. (1987) (32)
- Adjuvant trial of levamisole in patients with squamous cancer of the head and neck: a preliminary report. (1978) (31)
- Prognostic Biomarkers in Phase II Trial of Cetuximab-Containing Induction and Chemoradiation in Resectable HNSCC: Eastern Cooperative Oncology Group E2303 (2014) (31)
- Targeting the growth factors and angiogenesis pathways: Small molecules in solid tumors (2011) (31)
- Catheter tract seeding after percutaneous biliary drainage for pancreatic cancer (1986) (31)
- Multimodality approach to surgical management of locally advanced epidermoid carcinoma of the anorectum (1981) (30)
- Paclitaxel and concurrent radiation for gastric cancer. (2000) (30)
- Immunobiology of Operable Breast Cancer: An Assessment of Biologic Risk by Immunoparameters (1976) (29)
- An effective in vitro antitumor response against human pancreatic carcinoma with paclitaxel and daunorubicin by induction of both necrosis and apoptosis. (2004) (29)
- Prognostic analysis of survival in small breast cancers. (1998) (29)
- Preoperative chemoradiation coupled with aggressive resection as needed ensures near total control in advanced head and neck cancer. (1997) (28)
- Immunologic testing as a guide to cancer management. (1979) (28)
- Immunologic reactivity and prognosis in breast cancer (1980) (28)
- Monocyte dysfunction in human cancer (1983) (28)
- Colonoscopy: an essential monitoring technique after resection of colorectal cancer. (1983) (27)
- Surgery for gastrointestinal cancer (1997) (27)
- Immunocompetence testing in patients with one of the four common operable cancers--a review. (1978) (27)
- Surgical adjuvant therapy of malignant melanoma with Corynebacterium parvum (1981) (26)
- The changing mammogram. A primary indication for needle localization biopsy. (1986) (26)
- Carcinoma of the gallbladder (1993) (25)
- Concurrent chemoradiotherapy with weekly paclitaxel and carboplatin for locally advanced head and neck cancer: Long‐term follow‐up of a Brown University Oncology Group Phase II Study (HN‐53) (2008) (24)
- Bile Duct Carcinoma: Diagnosis and Treatment (1985) (24)
- Combination regional therapy for extremity sarcoma. A tricenter study. (1990) (24)
- Cetuximab, paclitaxel, carboplatin and radiation for esophageal and gastric cancer. (2006) (23)
- Targeting growth factors and angiogenesis; using small molecules in malignancy (2006) (23)
- Seroma prevention using fibrin glue during modified radical neck dissection in a rat model. (1988) (22)
- Concurrent platinum-based chemotherapy and hyperfractionated radiotherapy with late intensification in advanced head and neck cancer. (1997) (22)
- Systemic and adjuvant therapy for patients with pancreatic carcinoma (1996) (21)
- Cancers of the Anal Canal and Anal Margin (2003) (21)
- Concurrent paclitaxel, carboplatin, and radiotherapy in advanced head and neck cancers: a phase II study--preliminary results. (1997) (21)
- Surgical management of vascular malformations of the head and neck. (1986) (21)
- Are carcinoembryonic antigen levels of value in the curative management of colorectal cancer? (1981) (20)
- Reappraisal of surgical management of sarcoma of the buttock (1973) (20)
- Pancreatic cancer: An overview (1995) (20)
- Cetuximab, Paclitaxel, Carboplatin, and Radiation For Head and Neck Cancer: A Toxicity Analysis (2009) (20)
- Phase II induction cetuximab (C225), paclitaxel (P), and carboplatin (C) followed by chemoradiation with C225, P, C, and RT 68-72Gy for stage III/IV head and neck squamous cancer: Primary site organ preservation and disease control at 2 years (ECOG, E2303). (2010) (20)
- Isolated Chemotherapeutic Perfusion of Pelvis as Neoadjuvant or Palliative Therapy for Advanced Cancer of the Rectum (2008) (19)
- A phase I/II SECSG (Southeastern Cancer Study Group) pilot study of surgical adjuvant immunotherapy with vaccinia melanoma oncolysates (VMO). (1986) (19)
- Regional chemotherapy: overview. (2008) (19)
- Recurrence patterns with concurrent platinum-based chemotherapy and accelerated hyperfractionated radiotherapy in stage III and IV head and neck cancer patients. (1997) (19)
- A pharmacokinetic model and the clinical pharmacology of cis-platinum, 5-fluorouracil and mitomycin-C in isolated pelvic perfusion (1999) (19)
- Evaluation of the Pathologic and Prognostic Correlates of Estrogen Receptors in Primary Breast Cancer (1982) (19)
- Interleukin-2 production in head and neck cancer patients. (1985) (18)
- Basic fibroblast growth factor production and growth factor receptors as potential targets for melanoma therapy (1992) (18)
- Defective suppressor cell activity in cancer patients: A defect in immune regulation (1981) (18)
- Weekly Paclitaxel and Carboplatin Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck (2012) (18)
- Preoperative paclitaxel, carboplatin, and radiation therapy in advanced head and neck cancer (stage III and IV). (1999) (17)
- Salvage of pelvic recurrence of colorectal cancer (2010) (17)
- Severe hypoglycemia associated with terminal lymphomas: Report of five cases (1966) (17)
- Extramedullary plasmacytoma of upper respiratory tract. Recurrence after latency of thirty-six years. (1966) (16)
- Immune restoration with interleukin-2 in patients with squamous cell carcinoma of the head and neck. (1989) (16)
- Augmentation of the lymphokine-activated killer cell response in head and neck cancer patients by combination interleukin-2 and interferon-alpha. (1991) (15)
- Multiple cutaneous malignant melanomas with features of primary melanoma. (1981) (15)
- Surgical management of pelvic malignancy: role of extended abdominoperineal resection/exenteration/abdominal sacral resection. (2005) (15)
- ESSENTIAL MACROGLOBULINEMIA. REPORT OF A CASE INCLUDING IMMUNOFLUORESCENT AND ELECTRON MICROSCOPIC STUDIES. (1965) (15)
- Synchronous colon carcinomas: Molecular-genetic evidence for multicentricity (1996) (15)
- Epidermal growth factor stimulation and metastatic rate in human pancreatic carcinoma cell lines. (1990) (14)
- Changing gastric cancer treatment in the United States and the pursuit of quality. (2005) (14)
- Isolated chemotherapeutic perfusion of the pelvis for advanced rectal cancer (2003) (14)
- Cancer of the bile duct: the occult malignancy. (1975) (14)
- Neoplastic disease and thyrotoxicosis (1966) (13)
- Failures of electrocoagulation of primary carcinoma of the rectum. (1974) (13)
- A new mouse model of experimental melanoma for vaccine and lymphokine therapy. (1998) (13)
- DNCB reactivity and prognosis in 419 patients with malignant melanoma (1981) (13)
- Pelvic perfusion for advanced colorectal cancers. (2008) (13)
- The influence of incubation time and mitogen concentration on lymphocyte blastogenic response: determination of conditions that maximize population differences. (1980) (12)
- Molecular oncogene markers and their significance in cutaneous malignant melanoma (1998) (12)
- Technique and guidelines for needle localization biopsy of nonpalpable lesions of the breast. (1988) (12)
- Colorectal cancer. A blueprint for disease control through screening by primary care physicians. (1986) (12)
- Delayed hypersensitivity reactions in patients with carcinoma of the colon and rectum. (1977) (11)
- Taxol pretreatment of tumor targets amplifies natural killer cell mediated lysis. (1997) (11)
- INFLUENCE OF POLY(A)·POLY(U) ON IMMUNE RESPONSE IN CANCER PATIENTS (1976) (11)
- Immunization of mice with melanoma cells transfected to secrete the superantigen, staphylococcal enterotoxin A (1998) (10)
- Treatment of gallbladder cancer. (1994) (10)
- Malignant rectal carcinoid: a sequential multidisciplinary approach for successful treatment of hepatic metastases. (1985) (10)
- Carcinoma of the gallbladder and cholecystostomy. (1982) (9)
- B700 antigen as a component of an antimelanoma vaccine: formalinized extracellular antigens. (1992) (9)
- Pleural mesothelioma (1976) (9)
- Generation of cytotoxic antibodies to the B16 murine melanoma using a formalinized vaccine (1993) (9)
- Immunologic reactivity and prognosis in breast cancer. (1981) (9)
- Randomized trial of levamisole in patients with squamous cancer of the head and neck: a preliminary report. (1978) (9)
- Induction of interleukin‐2, natural killer cell activity and anti‐melanoma antibodies resulting from immunization of mice with formalinized extracellular antigens (FECA) of murine melanoma (1992) (9)
- Further characterization of a clinically relevant model of melanoma metastasis and an effective vaccine (1995) (9)
- Lymphocyte transformation in vitro to RII mouse milk antigen among woman with breast disease. (1976) (9)
- Paclitaxel disrupts polarized entry of membrane-permeable C6 ceramide into ovarian cancer cells resulting in synchronous induction of cell death (2013) (9)
- COMPLICATIONS OF ILEOSTOMY. (1965) (9)
- Isolated pelvic perfusion: plasma pharmacokinetics depend primarily on drug dosage and not the type of drug (2005) (9)
- The high-velocity pulmonary injury. Relation to traumatic wet lung syndrome. (1972) (8)
- The neoadjuvant therapy of colorectal hepatic metastases and the role of biologic sensitizing and resistance factors (2010) (8)
- Immunotherapy of mice with an irradiated melanoma vaccine coupled with interleukin-12 (1999) (8)
- Capacity of murine IL-12 to inhibit the development of primary melanoma tumors and to prevent lung metastases in the melanoma-challenged mice. (2002) (8)
- Thin (less than or equal to 1 mm) melanomas of the extremities are biologically favorable lesions not influenced by regression. (1985) (8)
- Reconstruction after the Tikhoff-Linberg procedure. (1982) (8)
- Electron microscopy of murine SJL/J disease (1969) (7)
- Leukocyte migration inhibition among breast cancer patients in response to various oncogenic viruses. (1980) (7)
- Lymphokine-activated effector cells: modulation of activity by cytokines. (1992) (7)
- Preimmunization of mice with formalinized extracellular antigens of melanoma in combination with IL‐2 and surgical resection increased survival and tumor control in metastatic melanoma model (1993) (7)
- Leukocyte migration inhibition response to various antigen preparations of autologous and homologous breast cancer in patients with primary breast cancer. (1979) (7)
- Extended Radical Pelvic Surgery Including Sacral Resection (1994) (7)
- Antitumor effects of polyvalent and monovalent vaccines coupled with interleukin-2 in a metastatic melanoma model. (1994) (7)
- Immunization of mice with irradiated melanoma tumor cells transfected to secrete lymphokines and coupled with IL-2 or GM-CSF therapy. (1996) (6)
- Lupus erythematosus complicated by the Chiari-Frommel syndrome and autoimmune thyroiditis. (1969) (6)
- A Low Rate of Central Nervous System Progression in a Phase II Trial of Outpatient Chemobiologic Therapy With Cisplatin, Temozolomide, Interleukin-2, and Interferon Alfa 2-B for Metastatic Malignant Melanoma (2005) (6)
- Osseous metastasis: its relationship to primary carcinoma of the head and neck. (1974) (6)
- Monocyte-mediated antibody-dependent cell-mediated cytotoxicity and spontaneous cytotoxicity in normals and cancer patients as assayed by human erythrocyte lysis. (1983) (6)
- Immunocompetence Testing in Patients with One of the Common Operable Cancer — A Review (1979) (6)
- Fate of ovary transposed during treatment of Hodgkin's disease. (1983) (5)
- Hepatic and biliary cancer (1987) (5)
- Behavior of the cell cycle-associated proteins in an unusual G0-arrestable cancer cell line. (1996) (5)
- Synergistic effect of interleukin-2 and a vaccine of irradiated melanoma cells transfected to secrete staphylococcal enterotoxin A (2004) (5)
- Head and neck sarcoma. (1997) (5)
- The leukocyte migration inhibition response to certain breast cancer-related antigens (MCF-7 and MuMTV): their potential as discriminants. (1979) (5)
- Antitumor effects of a normal human serum factor (normal human globulin fraction 1) on human tumor cells in vitro. (1984) (4)
- Colorectal Cancer: A Blueprint for Disease Control Through Screening by Primary Care Physicians (1986) (4)
- Inhibition of EGFR / PI 3 K / AKT cell survival pathway promotes TSA ' s effect on cell death and migration in human ovarian cancer cells (2006) (4)
- Surgical quality control — A Herculean task not easily achieved The Dutch gastric trial as a primer (1998) (4)
- Selective Organ Preservation in Operable Locally Advanced Head and Neck Squamous Cell Carcinomas Guided by Primary Site Restaging Biopsy: Long-Term Results of Two Sequential Brown University Oncology Group Chemoradiotherapy Studies (2011) (4)
- Decreased distant recurrence and preserved local control using dose dense induction weekly paclitaxel (P) and carboplatin (C) followed by concurrent paclitaxel, carboplatin and radiotherapy (CRT) in locally advanced head and neck squamous cell cancers (HN-SCC). (2004) (4)
- Cancer trends: the role of CEA in managing colorectal cancer. (1983) (4)
- Neoadjuvant therapy with high dose chemotherapy via isolated pelvic intra-abdominal perfusion with bone marrow stem cell support for advanced endometrial cancer. (2003) (4)
- Pancreatic cancer in 1994: diagnosis and treatment. (1994) (4)
- Surgical therapy of pancreatic cancer. (1998) (4)
- Hepatic artery infusion in surgical therapy of hepatic metastases from colorectal cancer (2008) (4)
- Hepatobiliary Scan with Delayed Gallbladder Visualization in a Case of Acute Appendicitis (1982) (4)
- Pancreatic cancer symposium: epidemiology, etiology, pathogenesis, and therapy. (1995) (4)
- Proceedings: Treatment of minimal breast cancer. (1974) (4)
- Cetuximab, Paclitaxel, Carboplatin, and Radiation for Head and Neck Cancer: A Survival Analysis of a Brown University Oncology Group Phase II Study (2014) (4)
- Antineoplastons: the controversy continues. (1993) (3)
- Arteriovenous fistulas of major vessels in the abdomen. (1971) (3)
- Pelvic soft tissue sarcomas present a challenge to therapists. (2001) (3)
- Sacral resection of posterior pelvic malignancy. (1995) (3)
- Tuberculous tenosynovitis in a patient with hyperuricemia. (1966) (3)
- Radical gastrectomy and lymphadenectomy: historic overview, surgical trends, and lessons from the past. (2005) (3)
- p16 protein status and response to treatment in a prospective clinical trial (ECOG 2303) of patients with head and neck squamous cell carcinoma (HNSCC). (2011) (3)
- Nude mouse model to study passive humoral immunotherapy directed against B16 F10 murine melanoma (1994) (3)
- Corynebacterium parvum toxicity in patients with limited and advanced malignancy. (1984) (2)
- Hepatic resection for colorectal metastasis (1995) (2)
- Pancreatic carcinoma in perspective: A continuing challenge (2)
- Rectal injuries. (1969) (2)
- Sphingolipid biology and its role in cancer development and therapy (2016) (2)
- Protein differences in human pancreatic cancer cell lines with diverse metastatic potential. (1990) (2)
- Leukocyte migration inhibition responses to MCF-7, murine mammary tumor virus, and Thomsen-Friedenreich antigen in a series of cancer patients. (1983) (2)
- The challenge of early gastric cancer: the need to optimize microstaging and therapy (2000) (2)
- Clinical pharmacokinetics of isolated pelvic perfusion. (2008) (2)
- Effect of different cancer treatment methods on immunity to an antigenic transplantable murine fibrosarcoma (Meth A). (1977) (2)
- What you can do about colorectal cancer. (1984) (2)
- An Overview of Colorectal Cancer Screening (2015) (2)
- Phase I/II study of induction weekly paclitaxel, ifosfamide and carboplatin (PIC) followed by chemoradiotherapy (CRT) in advanced head and neck squamous cell cancers (HN-SCC) (2004) (2)
- Comparative activities of certain antihistamines on inhibition of isolated rabbit auricles. (1962) (2)
- Targeting small molecules in cancer. (2007) (2)
- Levamisole as an immunoadjuvant: phase I study and application in breast cancer. (1978) (2)
- C6-ceramide's effect on KRAS-defined colorectal cancer cells treated with oxaliplatin, 5-fluoruracil with and without cetuximab. (2016) (1)
- Targeting Signaling Pathways in Cancer Therapy (2009) (1)
- The management of pancreatic carcinoma. a continuing challenge: Introduction (1996) (1)
- Transplanted reticulum cell sarcoma (rcs) of sjl mice. Abstr. (1969) (1)
- Case report 281. Low-grade cartilaginous tumor with "skip lesion". (1984) (1)
- A rationale for expanding the endpoints for clinical trials in advanced pancreatic carcinoma (1)
- Extremely Low Frequency Magnetic Field Exposure of Mitogen Stimulated Human T-lymphocytes (1999) (1)
- The effect of blocking the prosurvival AKT/P13K/mTOR and mutant KRAS-signaling pathways on chemotherapy resistance of pancreatic cancer. (2011) (1)
- Intrasplenic vaccination against experimental melanoma. (1996) (1)
- Predictive Biomarkers and Personalized Medicine Prognostic Biomarkers in Phase II Trial of Cetuximab-Containing Induction and Chemoradiation in Resectable HNSCC : Eastern Cooperative Oncology Group E 2303 (2014) (1)
- Case report 281 (2004) (1)
- Management of melanoma of the extremities (1985) (1)
- The impact of an educational workshop on colorectal screening practices. (1987) (1)
- Predictors for response to cetuximab in a prospective clinical trial (E2303) of patients with head and neck squamous cell carcinoma (HNSCC). (2012) (1)
- Abstract B104: Liposomal C6 Ceramide appears to potentiate chemotoxicity of paclitaxel, gemcitabine and cetuximab against aggressive pancreatic cancer. (2013) (1)
- Intravenous Corynebacterium parvum: an adjunct to chemotherapy for resistant advanced ovarian cancer. (1977) (1)
- Pelvic Surgery (2012) (1)
- Adjuvant and systemic therapy for pancreatic cancer (1995) (1)
- Common Problems in Cancer Surgery (1990) (1)
- Preoperative chemoradiation directed by primary site rebiopsy in stage III/IV squamous head and neck cancer is associated with high rate of local regional control, but is still plagued by long-term distant failure. (2004) (1)
- Pursuing colorectal cancer questions in Virginia. (1985) (1)
- Hepatic arterial infusion (HAI) of oxaliplatin in advanced hepatocellular cancer (HCC): A phase I study. (2006) (0)
- Abstract 3797: C6Ceramide as potential novel therapy for pancreatic cancer (2015) (0)
- Neoadjuvant pelvic perfusion may facilitate resection of pelvic recurrent rectal cancer. (2013) (0)
- Immunology for advanced breast cancer. (1978) (0)
- Screening hospital employees for colorectal cancer. (1983) (0)
- Sarcoma: a challenging frontier for the oncologist. (1997) (0)
- Predictive biomarkers in a phase II trial of weekly carboplatin (CBDCA), paclitaxel (P), and cetuximab (C) induction and chemoradiation (CRT) in patients (pts) with resectable stage III/IVa,b head and neck squamous cell carcinoma (HNSCC): Eastern Cooperative Oncology Group E2303. (2013) (0)
- Neoadjuvant/adjuvant therapy shows improved survival following surgical resection of advanced gastric cancer (2004) (0)
- Sjl/j disease, preneoplastic and neoplastic phases. Abstr. (1969) (0)
- Comparison of isolated pelvic perfusion, open pelvic perfusion, and pelvic arterial infusion with charcoal perfusion in a canine model (1993) (0)
- Gastric cancer - a continuing controversy: Does extra gastric lymphadenectomy (R2) alter survival? (1995) (0)
- l Clinical Investigation CONCURRENT PLATINUM-BASED CHEMOTHERAPY AND HYPERFRACTIONATED RADIOTHERAPY WITH LATE INTENSIFICATION IN ADVANCED HEAD AND NECK CANCER (1997) (0)
- More comments on hepatic artery infusion. (1997) (0)
- Head and neck oncology research— A summary of the second international head and neck oncology research conference (1988) (0)
- Evaluation of immune reactivity in cancer patients by the whole blood leukocyte stimulation (micro PHA) Technique (1977) (0)
- The management of pancreatic carcinoma … a continuing challenge: Introduction (0)
- Abstract 221: C6-ceramide sensitizes the aggressive L3-6 pancreatic cancer cell line to paclitaxel-mediated antitumor effects in vivo and in vitro (2010) (0)
- Engineered vaccines: from overview to a specific application. (1993) (0)
- Simplified isolated pelvic perfusion for recurrent anorectal melanoma: 345 (1993) (0)
- 28: Hepatic Artery Infusion - Pitfalls and Benefits (2003) (0)
- Isolated chemotherapeutic perfusion as neoadjuvant therapy for advanced/unresectable pelvic malignancy (2004) (0)
- Author reply (1997) (0)
- Cancer of the stomach in the United States: Some progress but mainly bad news (1994) (0)
- P127 Radical Radiation for Unknown Primary Squamous Cancer Yields High Control But Has Major Toxic Effects, Suggesting the Need for a New Treatment Paradigm (2006) (0)
- Diagnostic strategies for palpable and nonpalpable lesions of the breast. (1987) (0)
- Commentary (2001) (0)
- Invited commentary (1994) (0)
- Ceramide, a mediator of apoptosis, synergizes with paclitaxel to induce regression of the L3.6 human pancreatic carcinoma implanted in SCID mice. (2004) (0)
- C6-ceramide to restore sensitivity to cetuximab in KRAS-mutant colorectal cancer. (2015) (0)
- Potential for surgical salvage of recurrent rectal cancer is governed by patterns of recurrence and ability to achieve an R0 resection (2004) (0)
- Editorial regarding use of modified femoral vein approach as method for implanting a totally implantable access port in patients with synchrounous bilateral mastectomes (Chen et al.) (2008) (0)
- Invited commentary (1999) (0)
- Leukocyte Migration Inhibition Responses to MCF-7 , Murine Mammary Tumor Virus , and Thomsen-Friedenreich Antigen in a Series of Cancer Patients 1 (2006) (0)
- Surgical Management of Pelvic Malignancy (2005) (0)
- In response to Dr. Forastiere (1995) (0)
- Abstract 4767: C6 ceramide sensitizes multiple aggressive pancreatic cancer cell lines to gemcitabine, paclitaxel and cetuximab mediated anti tumor effectsin vivoandin vitro (2011) (0)
- New Approaches to Management of Advanced Posterior Pelvic Malignancy (1982) (0)
- Shc test as a strong prognostic indicator of disease outcome in early stage gastric cancer. (2006) (0)
- Preface. The evolution of regional therapy modalities. (2008) (0)
- RETROSPECTIVE RESULTS NEED PROSPECTIVE CONFIRMATION. AUTHOR'S REPLIES (1995) (0)
- Phase I/II study of induction weekly paclitaxel, ifosfamide and carboplatin (PIC) followed by chemoradiotherapy (CRT) in advanced head and neck squamous cell cancers (HN-SCC). (2004) (0)
- M1539 The Stage of Recurrence Is a Major Arbiter of RO Resectability and Outcome in Patients with Recurrent Rectal Cancer (2009) (0)
- Author's reply: Thyroid cancer (1984) (0)
- Corynebacterium parvum. (1976) (0)
- Although substantial (qol) quality of life problems may occur due to acute and delayed complications of therapy for advanced head & neck squamous cancer, overall long term qol is good/acceptable. (2006) (0)
- [Frontiers in Bioscience e175-180, November 1, 1998] 175 SURGICAL THERAPY OF PANCREATIC CANCER (1998) (0)
- Abstract 4294: C6 Ceramide potentiates paclitaxel and gemcitabine mediated antitumor effects against pancreatic cancer via inhibition of prosurvival PI3k/AKT/mTOR and ERK pathways (2019) (0)
- Hepatic artery infusion for recurrent or chemoresistant hepatic malignancy. (2011) (0)
- Effect of the apoptosis signal ceramide (C6) on antitumor activity of chemotherapeutic agents in SCID mice. (2016) (0)
- Acceleration of reticulum cell sarcoma in SJL mice chronically treated with heterologous antilymphocyte serum. (1969) (0)
- Multi option therapeutic strategy for hepatic metastases of colorectal cancer (2000) (0)
- Diagnostic and Management Issues in Gallbladder Carcinoma (2017) (0)
- Abstract 3734: Paclitaxel disrupts polarized entry of membrane permeable C6 ceramide into ovarian cancer cells resulting in synchronous induction of cell death (2012) (0)
- Aggressive regional therapy vs conventional treatment of patients with unresected liver metastases from colorectal cancer: A multivariate analysis focused on overall survival (2005) (0)
- Abstract 600: Liposomal C6 ceramide appears to potentiate enhanced chemotoxicity of pancreatic cancer. (2013) (0)
- Pancreatic cancer: Rhode island resectional experience (1998) (0)
- Hepatoma (1980) (0)
- C6-ceramide to induce sensitivity to cetuximab (Cet) in KRAS mutant colorectal cancer (CRC). (2016) (0)
- Commentary (Begossi/Wanebo): Surgery in the Older Patient (2002) (0)
- Systemic and adjuvant therapy for patients with pancreatic carcinoma (0)
- Treatment of Pancreatic Cancer: Current Limitations, Future Possibilities (2017) (0)
- Apoptosis signal ceramide c6 synergizes anti-tumor effects of paclitaxel oxaliplatin & cisplatin on growth of pancreatic cancer in SCID mice. (2006) (0)
- [Abdominosacral resection for locoregional recurrence rectal cancer]. (1999) (0)
- Hepatic artery infusion for recurrent or chemotherapy-resistant hepatic malignancy. (2011) (0)
- Phase I /II study of carboplatin with weekly ifosfamide and docetaxel in recurrent or metastatic head and neck squamous cell cancers (HN-SCC) (2004) (0)
- Phase I /II study of carboplatin with weekly ifosfamide and docetaxel in recurrent or metastatic head and neck squamous cell cancers (HN-SCC). (2004) (0)
- Effect of neoadjuvant pelvic perfusion on symptom control and resection of pelvic recurrent rectal cancer. (2015) (0)
- Invited commentary (2005) (0)
- Resection for recurrent colorectal liver metastases. (2001) (0)
- Current aspects of immunotherapy in cancer (1981) (0)
- Evaluation of a patient prior to second-look surgery. (1991) (0)
- Role of biologic therapy in surgical management of hepatic metastases (2010) (0)
- Monocyte macrophage mediated antibody dependent and independent cell mediated cyto toxicity in normals and cancer patients (1981) (0)
- An unusual complication of central venous catherization. (1979) (0)
- Surgical resection for carcinoma of the pancreas: A historical overview (1995) (0)
- High-velocity pulmonary injury. Relation to traumatic wet-lung syndrome. (1972) (0)
- Breast cancer management in the nineteen nineties. (1992) (0)
- Potential for surgical salvage of recurrent rectal cancer is governed by patterns of recurrence and ability to achieve an R0 resection. (2004) (0)
- Biologic and surgical challenge of colorectal hepatic metastases dedication to Dr. Leslie Blumgart and Dr. Henri Bismuth (2010) (0)
- Alterations of monocyte function in neoplastic diseases. (1979) (0)
- Surgery of advanced pelvic malignancy-the continued quest for solution (2002) (0)
- Use of restaging primary site biopsy to optimize selection of primary therapy in high stage (III/IV) squamous cancer (2008) (0)
- Risk factors in breast cancer. (1988) (0)
- Meeting the biologic challenge of colorectal metastases (2012) (0)
- Radiation‐associated sarcoma after recurrent colorectal primary tumor: A complex surgical case (2015) (0)
- Colorectal cancer: to screen or not to screen? (1981) (0)
- Impact of sentinel node staus and other risk factors on the clinical outcome of patients with head and neck melanoma patients (2005) (0)
- Leukocyte migration inhibition response to breast cancer antigens and to mouse mammary tumor virus in women with primary breast cancer. (1978) (0)
- Fine Needle Aspiration Cytology in Diagnosis and Management of Bone and Soft Tissue Tumors (1988) (0)
- Effect of C6Ceramide on chemotoxicity of gemcitabine against chemoresistant pancreatic cell lines. (2015) (0)
- Papillary carcinoma in the thyroglossal tract. (1979) (0)
- Commentary (2001) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Harold J. Wanebo,?
Harold J. Wanebo, is affiliated with the following schools:
